Long-term Impact of the Pneumococcal Conjugate Vaccine on Pneumococcal Nasopharyngeal Colonization and Immune Correlates for Disease Protection.
Phase of Trial: Phase IV
Latest Information Update: 23 Jan 2015
At a glance
- Drugs Pneumococcal 7-valent CRM197 vaccine conjugate (Primary)
- Indications Pneumococcal infections
- Focus Therapeutic Use
- 25 Sep 2012 Additional lead trial centres added as reported by ClinicalTrials.gov.
- 08 May 2008 The expected completion date for this trial is now 1 Dec 2008.
- 05 May 2008 Status changed from recruiting to in progress.